Market Cap
US$5.1b
Last Updated
2021/04/19 23:24 UTC
Data Sources
Company Financials +
Executive Summary
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. More Details
Rewards
Risk Analysis
Snowflake Analysis
Flawless balance sheet with proven track record.
Similar Companies
Share Price & News
How has Exponent's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: EXPO is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: EXPO's weekly volatility (4%) has been stable over the past year.
Market Performance
7 Day Return
-2.9%
EXPO
1.6%
US Professional Services
1.3%
US Market
1 Year Return
37.2%
EXPO
42.7%
US Professional Services
53.8%
US Market
Return vs Industry: EXPO underperformed the US Professional Services industry which returned 42.7% over the past year.
Return vs Market: EXPO underperformed the US Market which returned 53.9% over the past year.
Shareholder returns
| EXPO | Industry | Market | |
|---|---|---|---|
| 7 Day | -2.9% | 1.6% | 1.3% |
| 30 Day | 3.6% | 6.7% | 5.1% |
| 90 Day | 3.6% | 8.1% | 8.9% |
| 1 Year | 38.5%37.2% | 43.9%42.7% | 56.6%53.8% |
| 3 Year | 137.4%130.7% | 67.5%62.7% | 64.4%53.6% |
| 5 Year | 321.6%299.1% | 140.1%123.3% | 120.4%95.7% |
Long-Term Price Volatility Vs. Market
How volatile is Exponent's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Exponent (NASDAQ:EXPO) Has Rewarded Shareholders With An Exceptional 326% Total Return On Their Investment3 weeks ago | Simply Wall St
Exponent, Inc. (NASDAQ:EXPO) Has Got What It Takes To Be An Attractive Dividend Stock1 month ago | Simply Wall St
Exponent (NASDAQ:EXPO) Could Be A Buy For Its Upcoming DividendValuation
Is Exponent undervalued compared to its fair value and its price relative to the market?
62.8x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: EXPO ($100.86) is trading above our estimate of fair value ($53.13)
Significantly Below Fair Value: EXPO is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: EXPO is poor value based on its PE Ratio (64x) compared to the US Professional Services industry average (29x).
PE vs Market: EXPO is poor value based on its PE Ratio (64x) compared to the US market (22.5x).
Price to Earnings Growth Ratio
PEG Ratio: EXPO is poor value based on its PEG Ratio (6.9x)
Price to Book Ratio
PB vs Industry: EXPO is overvalued based on its PB Ratio (14.5x) compared to the US Professional Services industry average (3.3x).
Future Growth
How is Exponent forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
9.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EXPO's forecast earnings growth (9.3% per year) is above the savings rate (2%).
Earnings vs Market: EXPO's earnings (9.3% per year) are forecast to grow slower than the US market (18% per year).
High Growth Earnings: EXPO's earnings are forecast to grow, but not significantly.
Revenue vs Market: EXPO's revenue (9.6% per year) is forecast to grow faster than the US market (9.3% per year).
High Growth Revenue: EXPO's revenue (9.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EXPO's Return on Equity is forecast to be high in 3 years time
Past Performance
How has Exponent performed over the past 5 years?
15.2%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EXPO has high quality earnings.
Growing Profit Margin: EXPO's current net profit margins (21.8%) are higher than last year (21.1%).
Past Earnings Growth Analysis
Earnings Trend: EXPO's earnings have grown by 15.2% per year over the past 5 years.
Accelerating Growth: EXPO's earnings growth over the past year (0.2%) is below its 5-year average (15.2% per year).
Earnings vs Industry: EXPO earnings growth over the past year (0.2%) underperformed the Professional Services industry 1.4%.
Return on Equity
High ROE: EXPO's Return on Equity (22.8%) is considered high.
Financial Health
How is Exponent's financial position?
Financial Position Analysis
Short Term Liabilities: EXPO's short term assets ($366.8M) exceed its short term liabilities ($117.3M).
Long Term Liabilities: EXPO's short term assets ($366.8M) exceed its long term liabilities ($101.3M).
Debt to Equity History and Analysis
Debt Level: EXPO is debt free.
Reducing Debt: EXPO has not had any debt for past 5 years.
Debt Coverage: EXPO has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: EXPO has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is Exponent current dividend yield, its reliability and sustainability?
0.81%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: EXPO's dividend (0.79%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.24%).
High Dividend: EXPO's dividend (0.79%) is low compared to the top 25% of dividend payers in the US market (3.46%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, EXPO has been paying a dividend for less than 10 years.
Growing Dividend: EXPO's dividend payments have increased, but the company has only paid a dividend for 8 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (48.2%), EXPO's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: EXPO's dividends in 3 years are forecast to be well covered by earnings (48.8% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
19.4yrs
Average management tenure
CEO
Catherine Corrigan (51 yo)
2.92yrs
Tenure
US$2,607,550
Compensation
Dr. Catherine Ford Corrigan, Ph. D., PE, has been the President of Exponent Inc. since July 29, 2016 and its Chief Executive Officer and Director since May 31, 2018. She served as Group Vice President of T...
CEO Compensation Analysis
Compensation vs Market: Catherine's total compensation ($USD2.61M) is below average for companies of similar size in the US market ($USD6.51M).
Compensation vs Earnings: Catherine's compensation has increased by more than 20% in the past year.
Leadership Team
Experienced Management: EXPO's management team is seasoned and experienced (19.4 years average tenure).
Board Members
Experienced Board: EXPO's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: EXPO insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Exponent, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Exponent, Inc.
- Ticker: EXPO
- Exchange: NasdaqGS
- Founded: 1967
- Industry: Research and Consulting Services
- Sector: Commercial Services
- Market Cap: US$5.127b
- Shares outstanding: 51.80m
- Website: https://www.exponent.com
Number of Employees
Location
- Exponent, Inc.
- 149 Commonwealth Drive
- Menlo Park
- California
- 94025
- United States
Listings
Biography
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory complian...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/04/19 23:24 |
| End of Day Share Price | 2021/04/19 00:00 |
| Earnings | 2021/01/01 |
| Annual Earnings | 2021/01/01 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.